Ferjani S, Sassi I, Saidani M, Mhiri E, Ghariani A, Boutiba Ben Boubaker I, Slim L, Amine S
University of Tunis El Manar, Faculty of Medicine of Tunis, LR99ES09 Laboratory of Research 'Resistance to Antimicrobial Agents, Tunis, Tunisia.
Charles Nicolle Hospital, Laboratory of Microbiology, Tunis, Tunisia.
New Microbes New Infect. 2020 May 5;36:100690. doi: 10.1016/j.nmni.2020.100690. eCollection 2020 Jul.
The decreased affinity to β-lactams is usually caused by specific alterations in penicillin-binding protein 3 due to varieties of substitutions in gene. This study aimed to characterize the polymorphism of gene in 19 strains, isolated between 2014 and 2016 (different resistance phenotypes to β-lactams ( = 9) and susceptible strains ( = 10) used for comparative purposes). All strains were characterized for capsular type by PCR and agglutination tests and for β-lactam resistance by amplification and sequencing of . Biotyping and clonality were performed by API-NH and pulsed-field gel electrophoresis, respectively. Four strains were β-lactamase-negative ampicillin-resistant and five were β-lactamase-positive clavulanic-acid-resistant. One strain from each group was resistant to cefotaxime. Our isolates belonged mainly to biotype IV and I and were non-typeable and genetically unrelated. According to mutation profiles of their , strains were classified as group I ( = 3), group II ( = 4), group-III-like ( = 1) and group III ( = 1). All group II strains were further classified as subgroup IIb, except for one strain, which harboured a new mutation (N422I). Ampicillin MICs of β-lactamase-negative ampicillin-resistant strains were 6 to 12 times the MICs of susceptible strains. Only was detected in β-lactamase-positive clavulanic-acid-resistant strains, and was responsible for high MICs for ampicillin (>256 mg/L), whatever the mutational resistance group. The emergence of cefotaxime-resistant isolates in our country is a matter of concern and requires strict surveillance and rationalization of antibiotic use to preserve these molecules.
对β-内酰胺类药物亲和力的降低通常是由于基因中各种取代导致青霉素结合蛋白3发生特定改变所致。本研究旨在对2014年至2016年间分离出的19株菌株(为比较目的使用了对β-内酰胺类药物具有不同耐药表型的菌株(n = 9)和敏感菌株(n = 10))的基因多态性进行表征。通过PCR和凝集试验对所有菌株进行荚膜类型鉴定,并通过基因扩增和测序对β-内酰胺耐药性进行鉴定。分别通过API-NH和脉冲场凝胶电泳进行生物分型和克隆性分析。4株菌株为β-内酰胺酶阴性氨苄西林耐药,5株为β-内酰胺酶阳性克拉维酸耐药。每组各有1株菌株对头孢噻肟耐药。我们分离出的菌株主要属于生物型IV和I,无法分型且无基因相关性。根据其基因的突变谱,菌株被分为I组(n = 3)、II组(n = 4)、III组样(n = 1)和III组(n = 1)。除1株携带新突变(N422I)的菌株外,所有II组菌株均进一步分为IIb亚组。β-内酰胺酶阴性氨苄西林耐药菌株的氨苄西林MIC是敏感菌株MIC的6至12倍。在β-内酰胺酶阳性克拉维酸耐药菌株中仅检测到基因,无论其突变耐药组如何,该基因均导致氨苄西林的高MIC(>256 mg/L)。我国出现头孢噻肟耐药菌株令人担忧,需要进行严格监测并合理使用抗生素以保护这些药物。